Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Sentinel Lymph Node Navigation in Radical Esophagectomy for ESCC
NCT04173676Phase 1Unknown
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Dec 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Detection rate of sentinel lymph node at 1 year and Positive rate of sentinel lymph node at 1 year. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT04173676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04173676.